METIS TECHBIO-P's stock soared 5.01% during intraday trading on Wednesday, marking a significant recovery for the biotechnology company.
The sharp rise follows the company's formal clarification announcement addressing recent media reports claiming that the China Securities Regulatory Commission had sent supplementary information disclosure requests to the company and others. METIS TECHBIO-P explicitly stated that these reports were inaccurate and misleading, confirming it has not received any such request since obtaining its CSRC filing notice.
This clarification effectively dispelled market concerns that had previously caused the stock to plunge over 12% intraday, triggering the current recovery rebound as investor confidence was restored following the resolution of the regulatory uncertainty.
Comments